Weight loss plateaus on GLP-1 medications are expected
Learn more about the summit, and register here: #GLP1Summit #GLP1 #PrescriptionTrends #PrescribingTrends #PrescriptionData #Tirzepatide #Semaglutide #EHRData #ClinicalExpertLedAI #MedicalAI #HealthAI #HealthcareAI #AI #Innovation #RealWorldData #RWD Truvetas Post One week from today, our Director of Life Sciences Harshita Ravishankar, MD MPA, will be presenting at the inaugural GLP-1-Based Therapeutics Summit in Philadelphia on real-world GLP-1 prescribing trends gleaned from Truveta Data
Abstract In recent years, glucagon-like peptide 1 receptor agonists (GLP-1RAs) have become central in the treatment of type 2 diabetes (T2D)
Also, be sure to understand your insurance plans coverage criteria and whether you meet them
Zannad F, Cannon CP, Cushman WC, Bakris GL, Menon V, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Lam H, White WB, EXAMINE Investigators
What this means practically is that your choice of morning versus evening should be driven by side effect management and routine compatibility, not by chasing marginally different blood levels
